Afrocentric InvestmentJSE:ACT 52 3-Year ROIIC % is 28.37 as of Dec. 2025, which is 0% above its 10-year median of 28.34. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.08 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 76.9% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Afrocentric Investment's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 28.37%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Afrocentric Investment's 3-Year ROIIC % or its related term are showing as below:
JSE:ACT's 3-Year ROIIC % is ranked better than 76.9% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.28
vs JSE:ACT: 28.37
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Afrocentric Investment 3-Year ROIIC % Related Terms
Afrocentric Investment 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Afrocentric Investment's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ACT vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's 3-Year ROIIC % falls into.
Afrocentric Investment's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 159.178 (Dec. 2025) - 526.5622884 (Jun. 2022) )
/
( 3336.627 (Dec. 2025) - 4631.571 (Jun. 2022) )
=
-367.3842884
/
-1294.944
=
28.37%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Afrocentric Investment (JSE:ACT) has a 3-Year ROIIC % of 28.37 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Afrocentric Investment and its competitors. This is near median its historical median of 28.34. According to the industry distribution chart, Afrocentric Investment ranks #143 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 23.1%.
Is Afrocentric Investment's 3-Year ROIIC % too high?
Afrocentric Investment's current 3-Year ROIIC % of 28.37 is near median its 10-year median of 28.34. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.28. Afrocentric Investment's value of 28.37 is 764.9% above this industry median. Based on the distribution chart, Afrocentric Investment ranks #143 out of 619 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #143 out of 619 companies for 3-Year ROIIC %. This places Afrocentric Investment in the top 23% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.28. Afrocentric Investment's value of 28.37 is 764.9% above this benchmark. While the company's 10-year median is 28.34 vs. the industry median of 3.28, Afrocentric Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.28, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current 3-Year ROIIC % of 28.37 is 764.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current 3-Year ROIIC % is 28.37, which is near median its own 10-year median of 28.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.08, compared to a current price of R0.85 — trading 59.1% below its estimated fair value. The current 3-Year ROIIC % is 28.37, which is near median its 10-year median of 28.34 and 764.9% above the Healthcare Providers & Services industry median of 3.28. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current 3-Year ROIIC % is 28.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.85 is trading 59.1% below its estimated GF Value™ of R2.08.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
3-Year ROIIC %: 28.37 (near median its 10-year median of 28.34)
GF Value™: R2.08 vs. price of R0.85 (59.1% below fair value)
Industry Position: 764.9% above the Healthcare Providers & Services median (#143 of 619)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
